FDA Reproductive Health Cmte. Line-Up Set; First Priority Will Be WHI Results

The new roster of FDA's Reproductive Health Drugs Advisory Committee includes two members who have conducted research or educational activities on hormone replacement therapy sponsored by Wyeth